Manulife (Manufacturers Life Insurance)’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $812K | Sell |
57,948
-145
| -0.2% | -$2.03K | ﹤0.01% | 1921 |
|
|
2025
Q1 | $909K | Buy |
58,093
+7,137
| +14% | +$112K | ﹤0.01% | 1851 |
|
|
2024
Q4 | $710K | Sell |
50,956
-1,547
| -3% | -$21.6K | ﹤0.01% | 2066 |
|
|
2024
Q3 | $488K | Buy |
52,503
+12,180
| +30% | +$113K | ﹤0.01% | 2303 |
|
|
2024
Q2 | $375K | Buy |
40,323
+9,537
| +31% | +$88.7K | ﹤0.01% | 2325 |
|
|
2024
Q1 | $305K | Sell |
30,786
-2,721
| -8% | -$27K | ﹤0.01% | 2393 |
|
|
2023
Q4 | $108K | Buy |
33,507
+12,465
| +59% | +$40.3K | ﹤0.01% | 2795 |
|
|
2023
Q3 | $112K | Hold |
21,042
| – | – | ﹤0.01% | 2768 |
|
|
2023
Q2 | $201K | Buy |
21,042
+4,650
| +28% | +$44.3K | ﹤0.01% | 2611 |
|
|
2023
Q1 | $180K | Sell |
16,392
-676
| -4% | -$7.44K | ﹤0.01% | 2596 |
|
|
2022
Q4 | $253K | Buy |
17,068
+2,837
| +20% | +$42K | ﹤0.01% | 2414 |
|
|
2022
Q3 | $272K | Buy |
14,231
+79
| +0.6% | +$1.51K | ﹤0.01% | 2366 |
|
|
2022
Q2 | $302K | Buy |
14,152
+1,931
| +16% | +$41.2K | ﹤0.01% | 2392 |
|
|
2022
Q1 | $235K | Sell |
12,221
-3,207
| -21% | -$61.8K | ﹤0.01% | 2666 |
|
|
2021
Q4 | $318 | Buy |
15,428
+517
| +3% | +$11 | ﹤0.01% | 2568 |
|
|
2021
Q3 | $356K | Sell |
14,911
-1,208
| -7% | -$28.8K | ﹤0.01% | 2541 |
|
|
2021
Q2 | $440K | Buy |
16,119
+3,144
| +24% | +$85.8K | ﹤0.01% | 2526 |
|
|
2021
Q1 | $375K | Buy |
12,975
+888
| +7% | +$25.7K | ﹤0.01% | 2466 |
|
|
2020
Q4 | $340K | Buy |
12,087
+2,311
| +24% | +$65K | ﹤0.01% | 2436 |
|
|
2020
Q3 | $286K | Buy |
+9,776
| New | +$286K | ﹤0.01% | 2325 |
|